Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. [electronic resource]
Producer: 20020410Description: 1721-8 p. digitalISSN:- 0732-183X
- Adjuvants, Immunologic -- administration & dosage
- Aged
- Analysis of Variance
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- blood
- Chemotherapy, Adjuvant
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Leucovorin -- administration & dosage
- Levamisole -- administration & dosage
- Male
- Middle Aged
- Neoplasm Staging
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- Survival Analysis
- Thymidylate Synthase -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.